- New drugs in the treatment of venous thromboses - will synthetic pentasaccharide replace heparins?2002 | First Faculty of Medicine
- Tissue and clinical response by pentasaccharide prevention, phase 1Publication without faculty affiliation
- Pentasacharides in the treatment of acute pulmonary embolism2012 | Second Faculty of Medicine
- New drugs in the prevention and treatment of venous thromboses - will direct oral thrombin inhibitors and synthetic pentasaccharide replace heparins?Publication without faculty affiliation
- New drugs in the prevention and treatment of venous thromboses - will direct oral thrombin inhibitors and synthetic pentasaccharide replace heparins? (1)Publication without faculty affiliation
- Effective use of fondaparinux in patient with unresponsiveness to nadroparin2021 | First Faculty of Medicine
- Thromboembolism - Contemporary State and Perspectives2002 | First Faculty of Medicine
- New antithrombotics in the prevention of venous thromboembolia and new anti-platelet drugs2011 | Faculty of Medicine in Hradec Králové
- Stochastic Modeling of Flexible Biomolecules Applied to NMR Relaxation. 2. Interpretation of Complex Dynamics in Linear Oligosaccharides2012 | Faculty of Mathematics and Physics
- Dabigatran - clinical evidence for treatment in patients with thromboembolism2016 | First Faculty of Medicine
- Position of fondaparinux in current clinical pracitice2022 | First Faculty of Medicine, Third Faculty of Medicine
- Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc2022 | Faculty of Pharmacy in Hradec Králové
- Low molecular weight heparins - their significance in current practice2011 | Central Library of Charles University, Third Faculty of Medicine